title: Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model.
authors.forename: Takuro
authors.initials: T
authors.lastname: Arimura
authors.forename: Rika
authors.initials: R
authors.lastname: Sato
authors.forename: Noboru
authors.initials: N
authors.lastname: Machida
authors.forename: Hidenori
authors.initials: H
authors.lastname: Bando
authors.forename: Dong-Yun
authors.initials: DY
authors.lastname: Zhan
authors.forename: Sachio
authors.initials: S
authors.lastname: Morimoto
authors.forename: Ryo
authors.initials: R
authors.lastname: Tanaka
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Yamane
authors.forename: Gisèle
authors.initials: G
authors.lastname: Bonne
authors.forename: Akinori
authors.initials: A
authors.lastname: Kimura
mesh_terms: D000818:Animals; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy*; D004095:Dihydropyridines / Q000494:pharmacology*; D051379:Mice; D011724:Pyridazines / Q000494:pharmacology*; D016019:Survival Analysis; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D004095:Dihydropyridines; D011724:Pyridazines; C115124:Sch 00013